By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.The vaccine, named PTX-COVID19-B, is under development in Canada and......
The 20 per cent surge in GSK Consumer Healthcare's (GSKCH) scrip on Monday to its new 52-week high of Rs 3,651.80 was big but not surprising, given the proposed open offer by its foreign parent,......
UK-based Healthcare and drug major on Monday today said it has offered to hike stake in its Indian subsidiary, GlaxoSmithKline Consumer Healthcare, to up to 75 per cent which would entail an outgo......
While a merger means HUL taking over GSK Consumer’s assets, including its employees, any mention of retention of employees beyond the merger is missing in the deal. The employees of GSK......
GlaxoSmithKline’s fast-relief analgesic, Crocin Advance, might cause pain to the company. Rejecting its plea to exempt the medicine from price control, the National Pharmaceutical Pricing......
Two years after first stepping into the sensitivity toothpaste market with the launch of Sensodyne, GlaxoSmithKline Consumer Healthcare has overtaken archrival Colgate Sensitive, with a share of 26......